FDA’s Orange Book Dispute Resolution Process May Grow Teeth With FTC Patent Listing Challenges

 
• By Brenda Sandburg
Dispute book
FTC invokes new use of FDA process to challenge Orange Book patent listings • Source: Shutterstock

More from Generics

More from Biosimilars & Generics